Intellectual Property: Litigation (PRC Firms)
China
1 year ranked
Provided by King & Wood
Ms. Tai has more than 27 years' experience as an IP practitioner, and worked with one of China's largest IP firms for long time as the executive member before joining KWM.
Ms. Tai is one of the most influential figures in IP law in the pharmaceutical and healthcare sectors, and has represented many influential cases including the Viagra® (Sildenafil) and Lipitor® (Atrovastatin) for Pfizer, Brillinta® (Ticagrelor) for AstraZeneca, Xarelto® (Rivaroxaban) for Bayer, Actemra® (Tocilizumab) for Roche/Chugai, Victoza® (Liraglutide) for Novo Nordisk, Entresto® (Valsartan Sacubitril) and Revolade® (Eltrombopag) for Novartis, in the patent invalidation and infringement litigations.
Ms. Tai is well experienced with the communication with the courts and government authorities including CNIPA and NMPA for patent and drug regulatory issues.
Provided by Chambers
Tina Tai is a market veteran with three decades of experience in the IP space. Her expertise in patent invalidation matters is in high demand among pharmaceutical and healthcare companies.
Provided by Chambers
I am very satisfied with Tina in the invalidation and litigation proceedings. Her team is the top one in the industry.
我对邰红律师在无效和诉讼程序中的表现非常满意。她的团队是业内顶尖的。
Chambers is the leading data and intelligence partner for the legal sector.